SCHEDULE: Deep Track Capital Exits Allakos Inc. Stake

Sentiment:

Beneficial Ownership Change 14 August 2025 8:44 AM

Deep Track Capital and its affiliates have reported zero beneficial ownership in Allakos Inc. common stock, indicating a full divestment of their previous stake.

Worse than expectedDeep Track Capital and its affiliates have reduced their beneficial ownership in Allakos Inc. to 0 shares, indicating a complete divestment of their stake. This suggests a lack of confidence or a strategic reallocation of capital by a significant institutional investor.

Summary

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have filed an Amendment No. 2 to Schedule 13G for Allakos Inc.
The filing indicates that as of June 30, 2025, the reporting persons beneficially own 0 shares of Allakos Inc. common stock.
This represents 0.00% of the outstanding common stock.
The total outstanding common stock of Allakos Inc. was 90,376,972 shares as of May 5, 2025, based on the issuer's 10-Q filed on May 7, 2025.
The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of Allakos Inc.

Sentiment

Score: 3

Explanation: The filing indicates a complete divestment by Deep Track Capital and its affiliates, which can be interpreted as a negative signal regarding their outlook on Allakos Inc.'s future prospects.

Negatives

Deep Track Capital and its affiliates have fully divested their stake in Allakos Inc., reducing their beneficial ownership to 0 shares. This complete exit by a significant institutional investor may signal a lack of confidence in the company's future prospects or a strategic shift in their investment portfolio.

Future Outlook

Industry Context

This filing is a routine disclosure of an institutional investor's change in ownership. A complete divestment by a specialized biotech fund like Deep Track Capital could signal a re-evaluation of the company's prospects or a broader shift in investment strategy within the biotechnology sector by this specific fund.

Stakeholder Impact

Shareholders: Potential negative sentiment due to a significant institutional investor exiting their position, which could lead to downward pressure on the stock price.

Key Dates

Date	Description
2025-05-05	Date Allakos Inc. common stock outstanding (90,376,972 shares) was determined, per issuer's 10-Q.
2025-05-07	Date Allakos Inc. filed its 10-Q with the SEC.
2025-06-30	Date of event which requires filing of this statement.
2025-08-14	Date of signing of the Schedule 13G Amendment No. 2.

Recommendation

sell

The complete divestment of shares by Deep Track Capital, a specialized investment firm, suggests a loss of conviction in Allakos Inc.'s future performance. This action by a sophisticated institutional investor often precedes or reflects negative developments, prompting other investors to consider reducing or exiting their own positions.

Keywords

Allakos Inc., AKTS, Deep Track Capital, Schedule 13G, beneficial ownership, common stock, institutional investor, divestment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.